Concepts (326)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Argentina | 50 | 2024 | 232 | 4.410 |
Why?
|
| Hypertension | 26 | 2023 | 8455 | 1.860 |
Why?
|
| Exercise | 9 | 2023 | 5611 | 1.290 |
Why?
|
| Latin America | 16 | 2021 | 381 | 1.260 |
Why?
|
| Chile | 15 | 2020 | 237 | 1.190 |
Why?
|
| Uruguay | 13 | 2019 | 104 | 1.190 |
Why?
|
| Cardiovascular Diseases | 28 | 2024 | 15108 | 1.180 |
Why?
|
| Health Promotion | 5 | 2022 | 2194 | 1.110 |
Why?
|
| Diabetes Mellitus | 12 | 2023 | 5724 | 1.000 |
Why?
|
| Developing Countries | 14 | 2023 | 2789 | 0.840 |
Why?
|
| Nuclear Family | 1 | 2022 | 318 | 0.780 |
Why?
|
| Health Behavior | 6 | 2021 | 2630 | 0.700 |
Why?
|
| Food | 2 | 2021 | 769 | 0.700 |
Why?
|
| Prehypertension | 3 | 2016 | 61 | 0.700 |
Why?
|
| Urban Health | 1 | 2020 | 547 | 0.610 |
Why?
|
| Home Care Services | 3 | 2020 | 602 | 0.590 |
Why?
|
| Hypercholesterolemia | 3 | 2019 | 1149 | 0.590 |
Why?
|
| Obesity, Abdominal | 2 | 2016 | 361 | 0.560 |
Why?
|
| Religion | 1 | 2019 | 356 | 0.560 |
Why?
|
| Sodium, Dietary | 2 | 2017 | 418 | 0.560 |
Why?
|
| Primary Health Care | 12 | 2023 | 4551 | 0.540 |
Why?
|
| Quality Indicators, Health Care | 3 | 2021 | 1831 | 0.530 |
Why?
|
| Physical Exertion | 1 | 2018 | 695 | 0.530 |
Why?
|
| Commerce | 1 | 2021 | 591 | 0.520 |
Why?
|
| South America | 8 | 2019 | 181 | 0.520 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2017 | 281 | 0.520 |
Why?
|
| Public Health | 4 | 2023 | 2594 | 0.520 |
Why?
|
| Food Supply | 1 | 2021 | 517 | 0.510 |
Why?
|
| Prediabetic State | 2 | 2017 | 493 | 0.510 |
Why?
|
| Cross-Sectional Studies | 24 | 2024 | 24913 | 0.510 |
Why?
|
| Motivation | 3 | 2021 | 1968 | 0.500 |
Why?
|
| Program Evaluation | 2 | 2020 | 2485 | 0.500 |
Why?
|
| Prevalence | 22 | 2022 | 15194 | 0.480 |
Why?
|
| Blood Pressure | 11 | 2023 | 8541 | 0.480 |
Why?
|
| Urban Population | 2 | 2019 | 2018 | 0.470 |
Why?
|
| Health Services Accessibility | 4 | 2020 | 5133 | 0.450 |
Why?
|
| Cholesterol, LDL | 3 | 2019 | 2354 | 0.450 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2019 | 814 | 0.440 |
Why?
|
| Telemedicine | 7 | 2019 | 2853 | 0.440 |
Why?
|
| Risk Factors | 38 | 2024 | 72145 | 0.440 |
Why?
|
| Physicians, Primary Care | 1 | 2019 | 577 | 0.430 |
Why?
|
| Medication Adherence | 2 | 2023 | 2055 | 0.420 |
Why?
|
| Alcohol Drinking | 4 | 2021 | 3957 | 0.410 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2019 | 3915 | 0.410 |
Why?
|
| Middle Aged | 58 | 2023 | 213127 | 0.400 |
Why?
|
| Adult | 53 | 2023 | 213712 | 0.390 |
Why?
|
| Guatemala | 5 | 2022 | 142 | 0.370 |
Why?
|
| Quality Improvement | 2 | 2023 | 3738 | 0.370 |
Why?
|
| Antihypertensive Agents | 5 | 2023 | 2043 | 0.360 |
Why?
|
| Humans | 102 | 2024 | 742088 | 0.360 |
Why?
|
| Obesity | 9 | 2024 | 12705 | 0.350 |
Why?
|
| Sex Factors | 11 | 2019 | 10392 | 0.350 |
Why?
|
| Suicidal Ideation | 1 | 2018 | 1246 | 0.350 |
Why?
|
| Poverty | 7 | 2021 | 2646 | 0.340 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2022 | 3239 | 0.330 |
Why?
|
| Body Weight | 1 | 2019 | 4664 | 0.320 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 6 | 2021 | 3038 | 0.320 |
Why?
|
| Male | 62 | 2023 | 349538 | 0.320 |
Why?
|
| Caribbean Region | 4 | 2020 | 194 | 0.310 |
Why?
|
| Aged | 44 | 2023 | 162944 | 0.300 |
Why?
|
| Female | 63 | 2023 | 379592 | 0.300 |
Why?
|
| Quality of Life | 7 | 2020 | 12730 | 0.290 |
Why?
|
| Air Pollution, Indoor | 3 | 2019 | 855 | 0.280 |
Why?
|
| Depressive Disorder | 1 | 2019 | 3748 | 0.280 |
Why?
|
| Qualitative Research | 3 | 2022 | 2680 | 0.240 |
Why?
|
| Tuberculosis, Pulmonary | 2 | 2021 | 810 | 0.240 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 3151 | 0.230 |
Why?
|
| Diet | 6 | 2021 | 7923 | 0.230 |
Why?
|
| Health Surveys | 4 | 2019 | 4030 | 0.230 |
Why?
|
| Educational Status | 5 | 2018 | 2533 | 0.230 |
Why?
|
| Colorectal Neoplasms | 1 | 2023 | 6754 | 0.230 |
Why?
|
| Pakistan | 4 | 2016 | 296 | 0.230 |
Why?
|
| Depression | 2 | 2019 | 7733 | 0.220 |
Why?
|
| Spirometry | 4 | 2021 | 862 | 0.220 |
Why?
|
| Reproducibility of Results | 7 | 2023 | 19862 | 0.200 |
Why?
|
| Preventive Health Services | 3 | 2017 | 575 | 0.200 |
Why?
|
| Social Class | 3 | 2019 | 1995 | 0.200 |
Why?
|
| Residence Characteristics | 2 | 2021 | 2049 | 0.200 |
Why?
|
| Health Personnel | 4 | 2022 | 3210 | 0.200 |
Why?
|
| Cities | 3 | 2019 | 511 | 0.190 |
Why?
|
| Health Status | 4 | 2018 | 4030 | 0.190 |
Why?
|
| Kenya | 3 | 2023 | 685 | 0.190 |
Why?
|
| World Health Organization | 2 | 2024 | 1317 | 0.180 |
Why?
|
| Cost of Illness | 2 | 2020 | 1852 | 0.170 |
Why?
|
| Smoking | 7 | 2023 | 8969 | 0.170 |
Why?
|
| Depressive Disorder, Major | 1 | 2017 | 4628 | 0.170 |
Why?
|
| Marketing | 1 | 2021 | 208 | 0.170 |
Why?
|
| Peru | 3 | 2016 | 881 | 0.170 |
Why?
|
| Dyslipidemias | 2 | 2016 | 848 | 0.170 |
Why?
|
| South Africa | 4 | 2016 | 1728 | 0.160 |
Why?
|
| Socioeconomic Factors | 4 | 2021 | 7770 | 0.160 |
Why?
|
| Smoke | 1 | 2019 | 226 | 0.160 |
Why?
|
| Hospitals, Pediatric | 2 | 2017 | 1760 | 0.150 |
Why?
|
| Health Status Disparities | 2 | 2019 | 1794 | 0.150 |
Why?
|
| India | 4 | 2016 | 2187 | 0.150 |
Why?
|
| Income | 4 | 2020 | 1904 | 0.150 |
Why?
|
| Coronavirus | 1 | 2020 | 158 | 0.150 |
Why?
|
| Education, Pharmacy | 1 | 2017 | 35 | 0.150 |
Why?
|
| Ambulatory Care | 2 | 2021 | 2706 | 0.150 |
Why?
|
| Diet Surveys | 2 | 2019 | 1172 | 0.140 |
Why?
|
| Chronic Disease | 3 | 2022 | 9144 | 0.140 |
Why?
|
| Cohort Studies | 12 | 2021 | 40450 | 0.140 |
Why?
|
| Health Services Administration | 1 | 2017 | 64 | 0.140 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2020 | 839 | 0.140 |
Why?
|
| Age Factors | 9 | 2019 | 18355 | 0.140 |
Why?
|
| Secondary Prevention | 2 | 2020 | 1520 | 0.140 |
Why?
|
| China | 3 | 2016 | 2246 | 0.130 |
Why?
|
| Vulnerable Populations | 1 | 2021 | 685 | 0.130 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2016 | 120 | 0.130 |
Why?
|
| Risk Assessment | 5 | 2020 | 23320 | 0.130 |
Why?
|
| Geography | 1 | 2017 | 669 | 0.130 |
Why?
|
| Research Personnel | 1 | 2019 | 573 | 0.120 |
Why?
|
| Apolipoproteins | 1 | 2017 | 315 | 0.120 |
Why?
|
| Endothelium, Vascular | 2 | 2019 | 4455 | 0.120 |
Why?
|
| Psychological Theory | 1 | 2015 | 168 | 0.120 |
Why?
|
| Cholesterol, HDL | 2 | 2018 | 1813 | 0.120 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2016 | 314 | 0.120 |
Why?
|
| Capacity Building | 1 | 2017 | 248 | 0.120 |
Why?
|
| Education | 1 | 2017 | 543 | 0.120 |
Why?
|
| Cost-Benefit Analysis | 5 | 2021 | 5385 | 0.120 |
Why?
|
| Young Adult | 10 | 2022 | 56350 | 0.120 |
Why?
|
| Feasibility Studies | 2 | 2021 | 5062 | 0.120 |
Why?
|
| Patient Preference | 2 | 2013 | 886 | 0.120 |
Why?
|
| Delivery of Health Care | 3 | 2019 | 5304 | 0.120 |
Why?
|
| Biomedical Technology | 1 | 2016 | 221 | 0.110 |
Why?
|
| Triglycerides | 2 | 2018 | 2450 | 0.110 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2014 | 199 | 0.110 |
Why?
|
| Electrocardiography | 5 | 2019 | 6440 | 0.110 |
Why?
|
| Health Policy | 3 | 2020 | 2657 | 0.110 |
Why?
|
| Guidelines as Topic | 1 | 2019 | 1402 | 0.110 |
Why?
|
| Biomedical Research | 2 | 2019 | 3306 | 0.110 |
Why?
|
| Rural Population | 2 | 2020 | 2207 | 0.110 |
Why?
|
| Awareness | 1 | 2016 | 639 | 0.110 |
Why?
|
| Workplace | 1 | 2018 | 836 | 0.100 |
Why?
|
| Prospective Studies | 9 | 2023 | 53187 | 0.100 |
Why?
|
| Occupational Health | 1 | 2018 | 809 | 0.100 |
Why?
|
| Patient Satisfaction | 2 | 2016 | 3391 | 0.100 |
Why?
|
| Health Education | 1 | 2018 | 1053 | 0.100 |
Why?
|
| Primary Prevention | 1 | 2019 | 1166 | 0.100 |
Why?
|
| Education, Medical, Continuing | 1 | 2017 | 839 | 0.100 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2019 | 1541 | 0.100 |
Why?
|
| Housing | 1 | 2016 | 663 | 0.100 |
Why?
|
| Cholesterol | 2 | 2017 | 2895 | 0.090 |
Why?
|
| Cardiovascular System | 1 | 2018 | 827 | 0.090 |
Why?
|
| Patient Education as Topic | 2 | 2018 | 2275 | 0.090 |
Why?
|
| Odds Ratio | 3 | 2019 | 9846 | 0.090 |
Why?
|
| Coronary Disease | 2 | 2022 | 6078 | 0.090 |
Why?
|
| Government Programs | 2 | 2022 | 275 | 0.090 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2019 | 1341 | 0.090 |
Why?
|
| Nutrition Policy | 1 | 2014 | 488 | 0.090 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2019 | 2267 | 0.090 |
Why?
|
| Metabolic Diseases | 1 | 2016 | 657 | 0.090 |
Why?
|
| Early Detection of Cancer | 1 | 2023 | 3070 | 0.080 |
Why?
|
| Asia, Southeastern | 2 | 2019 | 111 | 0.080 |
Why?
|
| Logistic Models | 3 | 2019 | 13403 | 0.080 |
Why?
|
| Morbidity | 3 | 2020 | 1767 | 0.080 |
Why?
|
| Health Services Needs and Demand | 2 | 2017 | 1411 | 0.080 |
Why?
|
| Population Surveillance | 1 | 2019 | 2616 | 0.080 |
Why?
|
| Cardiology | 1 | 2019 | 1658 | 0.080 |
Why?
|
| Students | 1 | 2018 | 1647 | 0.080 |
Why?
|
| Health | 1 | 2011 | 390 | 0.080 |
Why?
|
| Respiratory Tract Infections | 1 | 2016 | 959 | 0.080 |
Why?
|
| Myocardial Infarction | 3 | 2019 | 11690 | 0.080 |
Why?
|
| Vital Capacity | 2 | 2021 | 922 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2023 | 9941 | 0.070 |
Why?
|
| Quality-Adjusted Life Years | 3 | 2021 | 1679 | 0.070 |
Why?
|
| Mortality | 1 | 2019 | 2857 | 0.070 |
Why?
|
| Nutrition Surveys | 1 | 2014 | 1656 | 0.070 |
Why?
|
| Dobutamine | 2 | 1997 | 123 | 0.070 |
Why?
|
| Body Mass Index | 4 | 2016 | 12695 | 0.070 |
Why?
|
| Dietary Supplements | 1 | 2019 | 3294 | 0.070 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2012 | 532 | 0.070 |
Why?
|
| Translations | 1 | 2006 | 64 | 0.070 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 15530 | 0.070 |
Why?
|
| Pandemics | 3 | 2022 | 8328 | 0.070 |
Why?
|
| Stroke | 3 | 2016 | 9963 | 0.070 |
Why?
|
| Inflammation | 2 | 2017 | 10578 | 0.070 |
Why?
|
| Forced Expiratory Volume | 2 | 2021 | 1741 | 0.070 |
Why?
|
| Research Design | 2 | 2018 | 5979 | 0.070 |
Why?
|
| Pregnancy Outcome | 1 | 2016 | 2795 | 0.070 |
Why?
|
| Feeding Behavior | 2 | 2015 | 3187 | 0.070 |
Why?
|
| Computer Simulation | 1 | 2019 | 6191 | 0.060 |
Why?
|
| Adolescent | 6 | 2019 | 85649 | 0.060 |
Why?
|
| C-Reactive Protein | 1 | 2017 | 3766 | 0.060 |
Why?
|
| Environmental Exposure | 2 | 2018 | 4231 | 0.060 |
Why?
|
| Principal Component Analysis | 2 | 2019 | 939 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 14720 | 0.060 |
Why?
|
| Time Factors | 7 | 2020 | 40054 | 0.060 |
Why?
|
| Biological Products | 1 | 2013 | 856 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2018 | 3336 | 0.060 |
Why?
|
| Patient Compliance | 1 | 2014 | 2680 | 0.060 |
Why?
|
| Antirheumatic Agents | 1 | 2013 | 1335 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2017 | 6249 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2018 | 11695 | 0.050 |
Why?
|
| Cross-Cultural Comparison | 1 | 2006 | 651 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2006 | 780 | 0.050 |
Why?
|
| Ghana | 1 | 2023 | 287 | 0.050 |
Why?
|
| Pediatrics | 1 | 2017 | 3462 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3130 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3236 | 0.050 |
Why?
|
| Administrative Personnel | 1 | 2022 | 187 | 0.050 |
Why?
|
| Quality of Health Care | 1 | 2016 | 4369 | 0.050 |
Why?
|
| Systems Analysis | 1 | 2022 | 171 | 0.050 |
Why?
|
| Language | 2 | 2011 | 1458 | 0.050 |
Why?
|
| Insulin | 1 | 2015 | 6575 | 0.050 |
Why?
|
| Africa, Eastern | 1 | 2019 | 71 | 0.040 |
Why?
|
| Asthma | 1 | 2018 | 5955 | 0.040 |
Why?
|
| Regression Analysis | 3 | 2018 | 6452 | 0.040 |
Why?
|
| Exercise Test | 2 | 1997 | 2075 | 0.040 |
Why?
|
| Biomass | 1 | 2019 | 125 | 0.040 |
Why?
|
| Cause of Death | 2 | 2020 | 3571 | 0.040 |
Why?
|
| Life Style | 3 | 2015 | 3824 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2022 | 77098 | 0.040 |
Why?
|
| Colombia | 1 | 2019 | 259 | 0.040 |
Why?
|
| Terminology as Topic | 1 | 2006 | 1548 | 0.040 |
Why?
|
| Forecasting | 2 | 2019 | 2948 | 0.040 |
Why?
|
| Internationality | 1 | 2023 | 1002 | 0.040 |
Why?
|
| Health Priorities | 1 | 2020 | 379 | 0.040 |
Why?
|
| Decision Support Techniques | 2 | 2018 | 1952 | 0.040 |
Why?
|
| Aged, 80 and over | 7 | 2019 | 57683 | 0.040 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2013 | 3695 | 0.040 |
Why?
|
| Models, Economic | 1 | 2021 | 713 | 0.040 |
Why?
|
| Policy Making | 1 | 2020 | 554 | 0.040 |
Why?
|
| Epidemiologic Studies | 1 | 2020 | 676 | 0.040 |
Why?
|
| Metabolic Equivalent | 1 | 2016 | 14 | 0.040 |
Why?
|
| Urban Health Services | 1 | 2017 | 179 | 0.040 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2022 | 923 | 0.030 |
Why?
|
| Calibration | 1 | 2019 | 815 | 0.030 |
Why?
|
| Interviews as Topic | 2 | 2013 | 2536 | 0.030 |
Why?
|
| Reminder Systems | 1 | 2019 | 370 | 0.030 |
Why?
|
| Incidence | 3 | 2020 | 20928 | 0.030 |
Why?
|
| Self Report | 2 | 2019 | 3548 | 0.030 |
Why?
|
| Insurance, Health | 2 | 2019 | 2493 | 0.030 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 1517 | 0.030 |
Why?
|
| Appointments and Schedules | 1 | 2019 | 414 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2021 | 1146 | 0.030 |
Why?
|
| Research Support as Topic | 1 | 2019 | 704 | 0.030 |
Why?
|
| Child | 3 | 2018 | 77478 | 0.030 |
Why?
|
| Risk | 2 | 2019 | 9679 | 0.030 |
Why?
|
| Brazil | 1 | 2019 | 1263 | 0.030 |
Why?
|
| Africa South of the Sahara | 1 | 2018 | 724 | 0.030 |
Why?
|
| Confidence Intervals | 2 | 2013 | 2970 | 0.030 |
Why?
|
| Treatment Outcome | 5 | 2021 | 62966 | 0.030 |
Why?
|
| Streptokinase | 1 | 1994 | 188 | 0.030 |
Why?
|
| Mentors | 1 | 2019 | 630 | 0.030 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 39004 | 0.030 |
Why?
|
| Asia | 1 | 2016 | 607 | 0.030 |
Why?
|
| Hospitalization | 1 | 2014 | 10232 | 0.030 |
Why?
|
| Bangladesh | 1 | 2016 | 687 | 0.030 |
Why?
|
| Africa | 1 | 2016 | 670 | 0.030 |
Why?
|
| Schools | 1 | 2022 | 1425 | 0.030 |
Why?
|
| Siblings | 1 | 2018 | 854 | 0.030 |
Why?
|
| Cardiotonic Agents | 1 | 1997 | 535 | 0.030 |
Why?
|
| Occupations | 1 | 2016 | 517 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2019 | 2295 | 0.030 |
Why?
|
| Interprofessional Relations | 1 | 2019 | 1008 | 0.030 |
Why?
|
| Coronary Care Units | 1 | 1994 | 214 | 0.030 |
Why?
|
| Medically Uninsured | 1 | 2019 | 852 | 0.030 |
Why?
|
| Family Characteristics | 1 | 2018 | 999 | 0.030 |
Why?
|
| Patient Discharge | 2 | 2014 | 3300 | 0.030 |
Why?
|
| Age Distribution | 1 | 2019 | 2900 | 0.030 |
Why?
|
| Angina, Unstable | 1 | 1997 | 926 | 0.030 |
Why?
|
| Health Resources | 1 | 2018 | 911 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2016 | 917 | 0.030 |
Why?
|
| Preventive Medicine | 1 | 2014 | 263 | 0.030 |
Why?
|
| Family | 1 | 2022 | 3144 | 0.030 |
Why?
|
| United States | 3 | 2016 | 69693 | 0.020 |
Why?
|
| Diffusion of Innovation | 1 | 2016 | 725 | 0.020 |
Why?
|
| Delphi Technique | 1 | 2014 | 778 | 0.020 |
Why?
|
| Social Support | 1 | 2019 | 2117 | 0.020 |
Why?
|
| Adolescent Behavior | 1 | 2018 | 1150 | 0.020 |
Why?
|
| Environment | 1 | 2015 | 1115 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2016 | 1123 | 0.020 |
Why?
|
| Markov Chains | 1 | 2012 | 969 | 0.020 |
Why?
|
| Heart Failure | 1 | 2012 | 10856 | 0.020 |
Why?
|
| Prognosis | 2 | 2019 | 29010 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2014 | 865 | 0.020 |
Why?
|
| Reference Values | 1 | 2015 | 4982 | 0.020 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2016 | 941 | 0.020 |
Why?
|
| Mothers | 1 | 2018 | 2163 | 0.020 |
Why?
|
| Psychometrics | 1 | 2016 | 2999 | 0.020 |
Why?
|
| Recurrence | 1 | 2019 | 8333 | 0.020 |
Why?
|
| Health Services Research | 1 | 2015 | 1834 | 0.020 |
Why?
|
| Choice Behavior | 1 | 2013 | 802 | 0.020 |
Why?
|
| Health Literacy | 1 | 2011 | 414 | 0.020 |
Why?
|
| Motor Activity | 1 | 2015 | 2714 | 0.020 |
Why?
|
| Thrombolytic Therapy | 1 | 1994 | 2161 | 0.020 |
Why?
|
| Caregivers | 1 | 2016 | 2074 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2018 | 3203 | 0.020 |
Why?
|
| Air Pollution | 1 | 2018 | 2284 | 0.020 |
Why?
|
| Spain | 1 | 2006 | 465 | 0.020 |
Why?
|
| Overweight | 1 | 2016 | 2366 | 0.020 |
Why?
|
| Air Pollutants | 1 | 2018 | 2814 | 0.020 |
Why?
|
| Weight Loss | 1 | 2015 | 2604 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2016 | 40955 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 2866 | 0.010 |
Why?
|
| Mass Screening | 1 | 2019 | 5238 | 0.010 |
Why?
|
| Health Status Indicators | 1 | 2008 | 968 | 0.010 |
Why?
|
| Parents | 1 | 2016 | 3387 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2016 | 2789 | 0.010 |
Why?
|
| Registries | 1 | 2018 | 8077 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2020 | 21719 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12242 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2008 | 2372 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 1994 | 2370 | 0.010 |
Why?
|
| Communication | 1 | 2015 | 3728 | 0.010 |
Why?
|
| Insurance Coverage | 1 | 2012 | 1895 | 0.010 |
Why?
|
| Lung | 1 | 2019 | 9826 | 0.010 |
Why?
|
| Physicians | 1 | 2018 | 4554 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2013 | 8297 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2012 | 10248 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2008 | 3418 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2014 | 7716 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 7276 | 0.010 |
Why?
|
| Disease Progression | 1 | 2015 | 13256 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2016 | 25575 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2011 | 13921 | 0.010 |
Why?
|
| Pregnancy | 1 | 2016 | 29087 | 0.010 |
Why?
|
| Infant | 1 | 2016 | 35070 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2008 | 5100 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1994 | 637 | 0.010 |
Why?
|
| Heparin | 1 | 1994 | 1636 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1994 | 6483 | 0.000 |
Why?
|
| Hemodynamics | 1 | 1994 | 4197 | 0.000 |
Why?
|
| Acute Disease | 1 | 1994 | 7141 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 1997 | 15056 | 0.000 |
Why?
|
Concepts
(326)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(18)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_